Dr. Guoping Zhao has accepted to be a CBA Scientific Advisor

Dr. Guoping Zhao has accepted to be a CBA Scientific Advisor

Dear CBA members, supporters and friends,

We have a very exciting news to share with you all!

Dr. Guoping Zhao (赵国屏), a member of Chinese Academy of Sciences, has accepted the invitation to join our organization as a CBA Scientific Advisor. Dr. Guoping Zhao is a molecular microbiologist in Shanghai Institute of Plant Physiology and Ecology (SIPPE), Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences. Dr. Zhao was Born in Shanghai and received his bachelors in microbiology from Fudan University in 1982 and his doctorate in biochemistry from Purdue University in 1990. He is currently the Executive Director of the China National Human Genome Center at Shanghai, a Director of Shanghai Biochips, a Director of the Chinese Society for Microbiology and Biotechnology, and the Vice Chairman of the Shanghai Society for Microbiology. In 2005 he was elected to the Chinese Academy of Sciences.

Dr. Zhao studies the correlation between microbial metabolic regulation and the structure and function of enzymes as well as the reaction mechanism to develop the microbial and protein biotechnology engineering. Dr. Zhao is a leading scientist in the area of microbial genome and functional genomics research, where among other things he completed the whole genome sequencing and annotation for leptospira interrogans, identified a number of key metabolic pathways and gene functions, which led to new ideas for studying pathogenic mechanisms. Dr. Zhao led the molecular epidemiology of SARS and SARS coronavirus evolution research and built a solid foundation for understanding the animal origins of viruses and the genome variation rules when they are spread from animal to human.

CBA is very honored to have Dr. Zhao join us at the 20th Annual Conference of CBA (2015, China). Dr. Zhao’s thought-provoking lecture attributes tremendously to the success of this 20th anniversary event of CBA.

Since its founding 20 years ago, CBA has been serving as a bridge between US and China in the field of bio-med research with the goal of bringing new pharmaceutical agents to commercial development and healthcare market. Among many US-based professional societies and associations, CBA stands out as one of the most active, vibrant and engaging organizations. Dr. Guoping Zhao’s wealth of scientific knowledge and experience in both US and Chinese scientific communities will be a great asset to CBA’s future growth and our continued involvement in scientific research and biopharmaceutical development in both countries.

Again, we are very honored and excited to have Dr. Guoping Zhao as a valuable addition to the CBA team. We look forward to working with Dr. Zhao to take CBA to a higher level.


CBA Leadership Team